Legal Representation
Attorney
Joshua S. Jarvis, Esq.
USPTO Deadlines
Next Deadline
175 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 14, 2026
Extension Available
Until January 14, 2026
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 12, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 12, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 14, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 11, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 11, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 11, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 11, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 10, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 23, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable software as a medical device (SaMD) for the purposes of diagnosing, preventing, and treating cancer; downloadable electronic publications in the nature of reports in the field of drug development.
Class 041
Providing online non-downloadable publications in the nature of reports in the field of drug development.
Class 042
Pharmaceutical research and development; scientific research and development, namely, inputting, collecting, defining, modeling, analyzing, and validating data related to gene signatures and biomarkers for the purposes of drug development; design, development, and implementation of software related to drug development; customizing software related to drug development; consulting services in the field of design and implementation of software for others in the field of drug development; consulting services for others in the field of design, planning, and implementation project management of scientific and pharmaceutical research; providing online non-downloadable software for accessing, viewing, analyzing, and sharing reports in the field of drug development and cancer diagnosis.
First Use Anywhere:
Dec 20, 2018
First Use in Commerce:
Jul 17, 2019
Class 045
Licensing of intellectual property.
Classification
International Classes
009
041
042
045